ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Prof. James Neaton
INSIGHT Statistical and Coordinating Centre, University of Minnesota
Study Chair - Samuel Brown, MD
Intermountain Medical Center/University of Utah
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
40 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Banner University Medical Center Tucson (site 206-004), 1625 N. Campbell Avenue
Tucson, Arizona, United States
- Ucsf Fresno (site 203-005), 155 N. Fresno Street
Fresno, California, United States
- Va Loma Linda Healthcare System (site 074-017), 11201 Benton Street
Loma Linda, California, United States
- Cedars-Sinai Medical Center (site 208-002), 8700 Beverly Boulevard
Los Angeles, California, United States
- Ronald Reagan Ucla Medical Center (site 203-002), 757 Westwood Plaza
Los Angeles, California, United States
- Ucsf Medical Center (site 203-001), Moffit-Long Hospital, 505 Parnassus Ave.
San Francisco, California, United States
- Ucsf Medical Center at Mount Zion (site 203-007), 1600 Divisadero St.
San Francisco, California, United States
- Stanford University Hospital & Clinics (site 203-003), 300 Pasteur Dr.
Stanford, California, United States
- University of Colorado Hospital (site 204-001), 12605 E. 16th Avenue
Aurora, Colorado, United States
- Denver Health Medical Center (site 204-004), 780 Delaware Street, Pavilion B
Denver, Colorado, United States
- Medstar Health Research Institute (site 009-021), 110 Irving St., Nw.
Washington D.C., District of Columbia, United States
- Washington Dc Va Medical Center (site 009-004), 50 Irving Street, Nw.
Washington D.C., District of Columbia, United States
- Emory University (site 301-008), Bldg. A, Suite 2236, 1365 Clifton Rd., Ne.
Atlanta, Georgia, United States
- Massachusetts General Hospital (site 202-002), 55 Fruit Street
Boston, Massachusetts, United States
- Baystate Medical Center (site 201-001), Critical Care Research, 759 Chestnut Street
Springfield, Massachusetts, United States
- Columbia University Irving Medical Center (site 301-027), 177 Fort Washington Ave.
New York, New York, United States
- Mount Sinai Medical Center (site 301-012), Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place
New York, New York, United States
- Montefiore Medical Center - Moses Hospital (site 206-001), 111 E. 210th Street
The Bronx, New York, United States
- Montefiore Medical Center - Weiler Campus (site 206-003), 111 E. 210th Street
The Bronx, New York, United States
- Duke University Hospital (site 301-006), 2301 Erwin Road
Durham, North Carolina, United States
- Wake Forest Baptist Health (site 210-001), Medical Center Blvd
Winston-Salem, North Carolina, United States
- University of Cincinnati Medical Center (site 207-003), 234 Goodman Street, Ml 0740
Cincinnati, Ohio, United States
- Cleveland Clinic Fairview Hospital (site 207-005), 18101 Lorain Ave.
Cleveland, Ohio, United States
- Cleveland Clinic Foundation (site 207-001), 9500 Euclid Ave.
Cleveland, Ohio, United States
- the Ohio State University Wexner Medical Center (site 207-004), 410 W. 10th Avenue
Columbus, Ohio, United States
- Cleveland Clinic Marymount Campus (site 207-006), 12300 Mccracken Road
Garfield Heights, Ohio, United States
- Cleveland Clinic Hillcrest Hospital (site 207-007), 6780 Mayfield Road
Mayfield Heights, Ohio, United States
- Oregon Health & Science University (site 208-003), 3181 Sw Sam Jackson Park Rd.
Portland, Oregon, United States
- Medical University of South Carolina (site 210-002), 96 Jonathan Lucas St., Csb 214
Charleston, South Carolina, United States
- Vanderbilt University Medical Center (site 212-001), 1211 Medical Center Drive
Nashville, Tennessee, United States
- Baylor, Scott and White Health (site 301-003), Baylor University Medical Center, 3500 Gaston Ave.
Dallas, Texas, United States
- Houston Methodist Hospital (site 301-028), 6565 Fannin Street
Houston, Texas, United States
- Texas Heart Institute (site 301-017), 6770 Bertner, Mc4-266
Houston, Texas, United States
- University of Texas Health Science Center (site 203-006), 7000 Fannin St.
Houston, Texas, United States
- Intermountain Medical Center (site 211-001), 5121 South Cottonwood Street
Murray, Utah, United States
- University of Utah Hospital (site 211-002), 50 North Medical Drive
Salt Lake City, Utah, United States
- Uva School of Medicine (site 210-003), University of Virginia Health System, University Hospital, 1215 Lee St.
Charlottesville, Virginia, United States
- Harborview Medical Center (site 208-001), 325 9th Ave.
Seattle, Washington, United States
- Swedish Medical Center (site 208-005), 747 Broadway
Seattle, Washington, United States
- West Virginia University Medicine (site 301-023), One Medical Center Drive
Morgantown, West Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Apr 2021
- Primary completion
- 22 Aug 2022
- Completion
- 20 Nov 2022
- Last update posted
- 24 Oct 2025
- Registered enrollment
- 473
- Registry id
- NCT04843761
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.